Anti-E3 ubiquitin-protein ligase MUL1 antibody [EPR20241] - BSA and Azide free
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal E3 ubiquitin-protein ligase MUL1 antibody. Carrier free. Suitable for IP, WB and reacts with Human samples.
View Alternative Names
C1orf166, GIDE, MAPL, MULAN, RNF218, MUL1, Mitochondrial ubiquitin ligase activator of NFKB 1, E3 SUMO-protein ligase MUL1, E3 ubiquitin-protein ligase MUL1, Growth inhibition and death E3 ligase, Mitochondrial-anchored protein ligase, Protein Hades, Putative NF-kappa-B-activating protein 266, RING finger protein 218, RING-type E3 ubiquitin transferase NFKB 1
- IP
Supplier Data
Immunoprecipitation - Anti-E3 ubiquitin-protein ligase MUL1 antibody [EPR20241] - BSA and Azide free (AB251503)
This data was developed using ab209263, the same antibody clone in a different buffer formulation.
E3 ubiquitin-protein ligase MUL1 was immunoprecipitated from 0.35 mg of HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate with ab209263 at 1/30 dilution.
Western blot was performed from the immunoprecipitate using ab209263 at 1/1000 dilution.
VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/10000 dilution.
Lane 1 : HeLa whole cell lysate, 10 μg (Input).
Lane 2 : ab209263 IP in HeLa whole cell lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab209263 in HeLa whole cell lysate.
Blocking and dilution buffer : 5% NFDM/TBST.
Exposure time : 3 minutes.
All lanes:
Immunoprecipitation - Anti-E3 ubiquitin-protein ligase MUL1 antibody [EPR20241] (<a href='/en-us/products/primary-antibodies/e3-ubiquitin-protein-ligase-mul1-antibody-epr20241-ab209263'>ab209263</a>)
Predicted band size: 40 kDa
Observed band size: 39 kDa
false
- WB
Supplier Data
Western blot - Anti-E3 ubiquitin-protein ligase MUL1 antibody [EPR20241] - BSA and Azide free (AB251503)
This data was developed using ab209263, the same antibody clone in a different buffer formulation.
Blocking and dilution buffer : 5% NFDM/TBST.
Negative control : Human thymus (PMID : 18591963)
All lanes:
Western blot - Anti-E3 ubiquitin-protein ligase MUL1 antibody [EPR20241] (<a href='/en-us/products/primary-antibodies/e3-ubiquitin-protein-ligase-mul1-antibody-epr20241-ab209263'>ab209263</a>) at 1/1000 dilution
Lane 1:
HEK-293 (Human epithelial cell line from embryonic kidney) whole cell lysate at 20 µg
Lane 2:
HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg
Lane 3:
PC-3 (Human prostate adenocarcinoma cell line) whole cell lysate at 20 µg
Lane 4:
Human fetal heart tissue lysate at 20 µg
Lane 5:
Human thymus tissue lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 40 kDa
Observed band size: 39 kDa
false
Exposure time: 15min
- WB
Supplier Data
Western blot - Anti-E3 ubiquitin-protein ligase MUL1 antibody [EPR20241] - BSA and Azide free (AB251503)
This data was developed using ab209263, the same antibody clone in a different buffer formulation.
Blocking and dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-E3 ubiquitin-protein ligase MUL1 antibody [EPR20241] (<a href='/en-us/products/primary-antibodies/e3-ubiquitin-protein-ligase-mul1-antibody-epr20241-ab209263'>ab209263</a>) at 1/1000 dilution
All lanes:
A431 (Human epidermoid carcinoma cell line) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 40 kDa
Observed band size: 39 kDa
false
Exposure time: 15s
Reactivity data
Product details
ab251503 is the carrier-free version of ab209263.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
MUL1 regulates numerous cellular processes such as apoptosis mitophagy and the mitochondrial dynamics by modulating the stability of target proteins. MUL1 operates independently and does not require a specific E2 enzyme for its function. Additionally it participates in cellular homeostasis by mediating the degradation of proteins that impact mitochondrial fusion and fission events. Since MUL1 forms part of the regulatory mechanisms governing cellular adaptation and survival its levels and activity are finely controlled within the cell.
Pathways
MUL1 is actively involved in the mitophagy and DNA damage response pathways. Its role in the mitophagy pathway links MUL1 to PINK1 and PARKIN proteins that are critical for the removal of damaged mitochondria. In the context of the DNA damage response MUL1 functions to reprogram metabolic pathways yielding protection against cellular stress. This activity associates it with proteins like p53 a well-known tumor suppressor anchoring its presence in mechanisms of cellular defense.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com